JPWO2020218951A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020218951A5 JPWO2020218951A5 JP2021563239A JP2021563239A JPWO2020218951A5 JP WO2020218951 A5 JPWO2020218951 A5 JP WO2020218951A5 JP 2021563239 A JP2021563239 A JP 2021563239A JP 2021563239 A JP2021563239 A JP 2021563239A JP WO2020218951 A5 JPWO2020218951 A5 JP WO2020218951A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- antigen
- binding fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2019112296 | 2019-04-23 | ||
RU2019112296A RU2734432C1 (ru) | 2019-04-23 | 2019-04-23 | Моноклональное антитело, которое специфически связывается с GITR |
PCT/RU2020/050080 WO2020218951A2 (fr) | 2019-04-23 | 2020-04-23 | Anticorps monoclonal se liant spécifiquement à gitr |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2022532991A JP2022532991A (ja) | 2022-07-21 |
JPWO2020218951A5 true JPWO2020218951A5 (fr) | 2023-05-02 |
Family
ID=69821666
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021563239A Pending JP2022532991A (ja) | 2019-04-23 | 2020-04-23 | Gitrに特異的に結合するモノクローナル抗体 |
Country Status (22)
Country | Link |
---|---|
US (1) | US20220213209A1 (fr) |
EP (1) | EP3964525A4 (fr) |
JP (1) | JP2022532991A (fr) |
KR (1) | KR20220010501A (fr) |
CN (1) | CN110903392B (fr) |
AR (1) | AR118763A1 (fr) |
AU (1) | AU2020261207A1 (fr) |
BR (1) | BR112021021281A2 (fr) |
CA (1) | CA3137822A1 (fr) |
CL (1) | CL2021002792A1 (fr) |
CO (1) | CO2021014153A2 (fr) |
EA (1) | EA202192907A1 (fr) |
IL (1) | IL287531A (fr) |
JO (1) | JOP20210286A1 (fr) |
MA (2) | MA54969A1 (fr) |
MX (1) | MX2021012962A (fr) |
PE (1) | PE20220144A1 (fr) |
RU (1) | RU2734432C1 (fr) |
TW (1) | TWI803718B (fr) |
UY (1) | UY38672A (fr) |
WO (1) | WO2020218951A2 (fr) |
ZA (1) | ZA202109374B (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111732658B (zh) * | 2020-06-28 | 2022-04-26 | 英诺湖医药(杭州)有限公司 | 一组gitr单克隆抗体及其医药用途 |
CN112540179B (zh) * | 2020-08-06 | 2023-07-07 | 武汉天德生物科技有限公司 | 一种测试ApoE4蛋白含量的ELISA试剂盒 |
CN112362876B (zh) * | 2020-08-06 | 2023-12-15 | 武汉天德生物科技有限公司 | 一种检测早期老年痴呆症的胶体金试纸条及其制备方法 |
CN111763257B (zh) * | 2020-09-01 | 2020-12-15 | 北京百奥赛图基因生物技术有限公司 | 抗gitr抗体及其用途 |
CN114920845A (zh) * | 2020-12-31 | 2022-08-19 | 中元汇吉生物技术股份有限公司 | 特异性结合人IgG4的蛋白及其应用 |
Family Cites Families (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
US5179017A (en) | 1980-02-25 | 1993-01-12 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
US4634665A (en) | 1980-02-25 | 1987-01-06 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
US4510245A (en) | 1982-11-18 | 1985-04-09 | Chiron Corporation | Adenovirus promoter system |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US4740461A (en) | 1983-12-27 | 1988-04-26 | Genetics Institute, Inc. | Vectors and methods for transformation of eucaryotic cells |
US5168062A (en) | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
GB2183662B (en) | 1985-04-01 | 1989-01-25 | Celltech Ltd | Transformed myeloma cell-line and a process for the expression of a gene coding for a eukaryotic polypeptide employing same |
US4968615A (en) | 1985-12-18 | 1990-11-06 | Ciba-Geigy Corporation | Deoxyribonucleic acid segment from a virus |
GB8601597D0 (en) | 1986-01-23 | 1986-02-26 | Wilson R H | Nucleotide sequences |
US4959455A (en) | 1986-07-14 | 1990-09-25 | Genetics Institute, Inc. | Primate hematopoietic growth factors IL-3 and pharmaceutical compositions |
US5567610A (en) | 1986-09-04 | 1996-10-22 | Bioinvent International Ab | Method of producing human monoclonal antibodies and kit therefor |
US4912040A (en) | 1986-11-14 | 1990-03-27 | Genetics Institute, Inc. | Eucaryotic expression system |
IL85035A0 (en) | 1987-01-08 | 1988-06-30 | Int Genetic Eng | Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same |
GB8717430D0 (en) | 1987-07-23 | 1987-08-26 | Celltech Ltd | Recombinant dna product |
GB8809129D0 (en) | 1988-04-18 | 1988-05-18 | Celltech Ltd | Recombinant dna methods vectors and host cells |
US5175384A (en) | 1988-12-05 | 1992-12-29 | Genpharm International | Transgenic mice depleted in mature t-cells and methods for making transgenic mice |
US5229275A (en) | 1990-04-26 | 1993-07-20 | Akzo N.V. | In-vitro method for producing antigen-specific human monoclonal antibodies |
EP0546073B1 (fr) | 1990-08-29 | 1997-09-10 | GenPharm International, Inc. | production et utilisation des animaux non humains transgeniques capable de produire des anticorps heterologues |
US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
US5571894A (en) | 1991-02-05 | 1996-11-05 | Ciba-Geigy Corporation | Recombinant antibodies specific for a growth factor receptor |
US6407213B1 (en) | 1991-06-14 | 2002-06-18 | Genentech, Inc. | Method for making humanized antibodies |
US5587458A (en) | 1991-10-07 | 1996-12-24 | Aronex Pharmaceuticals, Inc. | Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof |
DE69333807T2 (de) | 1992-02-06 | 2006-02-02 | Chiron Corp., Emeryville | Marker für krebs und biosynthetisches bindeprotein dafür |
US5641870A (en) | 1995-04-20 | 1997-06-24 | Genentech, Inc. | Low pH hydrophobic interaction chromatography for antibody purification |
US5869046A (en) | 1995-04-14 | 1999-02-09 | Genentech, Inc. | Altered polypeptides with increased half-life |
DE19544393A1 (de) | 1995-11-15 | 1997-05-22 | Hoechst Schering Agrevo Gmbh | Synergistische herbizide Mischungen |
US6517529B1 (en) | 1999-11-24 | 2003-02-11 | Radius International Limited Partnership | Hemodialysis catheter |
AU2004244626A1 (en) * | 2003-05-23 | 2004-12-09 | The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services | GITR ligand and GITR ligand-related molecules and antibodies and uses thereof |
EP2385069A3 (fr) | 2003-11-12 | 2012-05-30 | Biogen Idec MA Inc. | Variantes de polypeptides Fc se liant au récepteur (FcRn) néonatal, protéines Fc dimèriques et procédés correspondants |
US20110123440A1 (en) | 2005-03-29 | 2011-05-26 | Genevieve Hansen | Altered Antibody FC Regions and Uses Thereof |
EP1899477A4 (fr) | 2005-07-01 | 2010-01-20 | Medimmune Inc | Approche integree permettant de generer des applications therapeutiques a base de proteine multidomaine |
KR101790802B1 (ko) * | 2009-09-03 | 2017-10-27 | 머크 샤프 앤드 돔 코포레이션 | 항-gitr 항체 |
TW201605896A (zh) | 2013-08-30 | 2016-02-16 | 安美基股份有限公司 | Gitr抗原結合蛋白 |
RS61678B1 (sr) * | 2014-05-28 | 2021-05-31 | Agenus Inc | Anti-gitr antitela i postupci za njihovu primenu |
WO2015187835A2 (fr) | 2014-06-06 | 2015-12-10 | Bristol-Myers Squibb Company | Anticorps anti récepteur du facteur de nécrose tumorale induit par glucocorticoïdes (gitr) et leurs utilisations |
AU2016206682B2 (en) * | 2015-01-14 | 2021-11-11 | The Brigham And Women's Hospital, Inc. | Treatment of cancer with anti-LAP monoclonal antibodies |
CN108473579B (zh) | 2015-10-22 | 2022-03-01 | 埃博灵克斯股份有限公司 | Gitr激动剂 |
EP3383431A4 (fr) | 2015-12-02 | 2019-08-28 | Agenus Inc. | Anticorps anti-gitr et leurs méthodes d'utilisation |
KR102495601B1 (ko) | 2016-06-10 | 2023-02-06 | 리제너론 파마슈티칼스 인코포레이티드 | 항-gitr 항체 및 그것의 사용 |
US20190263919A1 (en) * | 2016-07-01 | 2019-08-29 | Five Prime Therapeutics, Inc. | Combined anti tumor therapy with a gitr agonist and cpg |
CA3033665A1 (fr) * | 2016-08-12 | 2018-02-15 | Janssen Biotech, Inc. | Anticorps de membres de la superfamille anti-tnfr modifies par fc ayant une activite agoniste amelioree et leurs procedes d'utilisation |
CA3042727A1 (fr) * | 2016-11-19 | 2018-05-24 | Potenza Therapeutics, Inc. | Proteines de liaison a un antigene anti-gitr et leurs procedes d'utilisation |
KR20190124753A (ko) * | 2017-03-03 | 2019-11-05 | 리나트 뉴로사이언스 코프. | 항-gitr 항체 및 이의 사용 방법 |
TWI788340B (zh) * | 2017-04-07 | 2023-01-01 | 美商必治妥美雅史谷比公司 | 抗icos促效劑抗體及其用途 |
-
2019
- 2019-04-23 RU RU2019112296A patent/RU2734432C1/ru active
- 2019-12-03 CN CN201911222245.8A patent/CN110903392B/zh active Active
- 2019-12-03 TW TW108144110A patent/TWI803718B/zh active
-
2020
- 2020-04-22 UY UY0001038672A patent/UY38672A/es unknown
- 2020-04-23 JP JP2021563239A patent/JP2022532991A/ja active Pending
- 2020-04-23 MA MA54969A patent/MA54969A1/fr unknown
- 2020-04-23 AU AU2020261207A patent/AU2020261207A1/en active Pending
- 2020-04-23 MX MX2021012962A patent/MX2021012962A/es unknown
- 2020-04-23 WO PCT/RU2020/050080 patent/WO2020218951A2/fr unknown
- 2020-04-23 KR KR1020217038209A patent/KR20220010501A/ko unknown
- 2020-04-23 BR BR112021021281A patent/BR112021021281A2/pt unknown
- 2020-04-23 EP EP20794288.9A patent/EP3964525A4/fr active Pending
- 2020-04-23 JO JOP/2021/0286A patent/JOP20210286A1/ar unknown
- 2020-04-23 AR ARP200101146A patent/AR118763A1/es unknown
- 2020-04-23 PE PE2021001765A patent/PE20220144A1/es unknown
- 2020-04-23 EA EA202192907A patent/EA202192907A1/ru unknown
- 2020-04-23 US US17/605,933 patent/US20220213209A1/en active Pending
- 2020-04-23 CA CA3137822A patent/CA3137822A1/fr active Pending
- 2020-06-30 MA MA55390A patent/MA55390B1/fr unknown
-
2021
- 2021-10-22 CO CONC2021/0014153A patent/CO2021014153A2/es unknown
- 2021-10-22 CL CL2021002792A patent/CL2021002792A1/es unknown
- 2021-10-24 IL IL287531A patent/IL287531A/en unknown
- 2021-11-22 ZA ZA2021/09374A patent/ZA202109374B/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7273101B2 (ja) | Cd38に結合する抗体治療剤 | |
CN107151269B (zh) | 一种pdl-1抗体、其药物组合物及其用途 | |
JP6779299B2 (ja) | 抗pd−l1抗体およびその使用 | |
US11987635B2 (en) | Anti-4-1BB antibodies and methods of making and using thereof | |
JP2020501531A5 (fr) | ||
JP7474193B2 (ja) | 多重特異性抗体とその作製及び使用方法 | |
JP2020529864A (ja) | 多重特異性抗体とその作製及び使用方法 | |
JP2013502913A5 (fr) | ||
KR20220110177A (ko) | 항인간 클라우딘 18.2 항체 및 그의 적용 | |
WO2021115303A1 (fr) | Anticorps monoclonal anti-claudin18.2, son procédé de préparation et son utilisation | |
JP2024016024A5 (fr) | ||
US20230340119A1 (en) | Composition of triax antibodies and method of making and using thereof | |
WO2019076277A1 (fr) | Utilisations d'un anticorps anti-pd-1 et d'un anticorps anti-lag-3 conjointement dans la préparation d'un médicament pour le traitement d'une tumeur | |
WO2021037007A1 (fr) | Anticorps anti pd-l1 et son utilisation | |
JPWO2020043152A5 (fr) | ||
JPWO2020218951A5 (fr) | ||
WO2022127066A1 (fr) | Anticorps bispécifique pour neutraliser de manière spécifique un signal tgf-β de lymphocytes t auxiliaires, combinaison pharmaceutique et utilisation associées | |
TW202200620A (zh) | 抗flt3抗體及組合物 | |
JPWO2020012036A5 (fr) | ||
Gupta et al. | Therapeutic human monoclonal antibodies | |
CN106963950B (zh) | 用于治疗肿瘤的联合用药物 | |
RU2783685C2 (ru) | Анти-pd-l1 антитело и его применение | |
WO2022057910A1 (fr) | Polythérapies ciblant des voies c5ar et pd-1/pd-l1 | |
US20220169736A1 (en) | Combinations of anti-ildr2 antibodies and pd-1 antagonists | |
EP4357367A1 (fr) | Composition pharmaceutique et son utilisation |